Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors
Abroad (travel likely)RecruitingPHASE1
Conditions
Solid Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Children's National Hospital, Washington D.C., District of Columbia, United States
Contact: Principal Investigator (Amy Hont, MD)